A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00145171 |
|
Recruitment Status :
Completed
First Posted : September 5, 2005
Last Update Posted : September 5, 2005
|
Sponsor:
Mylan Bertek Pharmaceuticals
Information provided by:
Mylan Bertek Pharmaceuticals
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Completed |
|---|---|
| Primary Completion Date : | No date given |
| Study Completion Date : | August 2002 |